Reliance | Bernstein has maintained an 'outperform' rating on Reliance with a target of Rs 3,040 per share. It says that clean energy represents new growth pillar with $2 trillion investment in India through 2050.

Gland Pharma | Bernstein has maintained an 'outperform' rating on Gland Pharma with a target of Rs 1,702 per share. It says for most of the top 10 molecules, it sees partner market shares recovering from a trough.

Tata Motors | Morgan Stanley has maintained an 'overweight' rating on Tata Motors with a target of Rs 617 per share. It says Tata-supported EV transition should support a sustainable turnaround for JLR.

Hero MotoCorp | CLSA has downgraded its rating on Hero MotoCrop to 'sell' with a target of Rs 2,708 per share. It says that successful implementation of strategy and recovery in the entry segment remain key.

Hero MotoCorp | Citi has maintained a 'buy' rating on Hero MotoCorp with a target of Rs 3,650 per share. It says the demand outlook is positive and the management targets strong profitable growth.